מדינה: בלארוס
שפה: רוסית
מקור: Министерством здравоохранения Республики (Центр экспертиз и испытаний в здравоохранении)
Haemonetics Corporation, СОЕДИНЕННЫЕ ШТАТЫ АМЕРИКИ
изделия медицинского назначения
Haemonetics Corporation
2018-05-31
HAEMONETICS CORPORATION 400 Wood Road, Braintree, Massachusetts 02184, USA Visit us on the Web at WWW.HAEMONETICS.COM 127784-00 AA : 2020-03 ACD-A ACID CITRATE DEXTROSE - FORMULA A (ACD-A) - ANTICOAGULANT SOLUTION _SOLUTIONS FOR BLOOD COMPONENT COLLECTION BY APHERESIS_ 0426C-NC, 0427C-NC, 0427K-00 ENGLISH ACID CITRATE DEXTROSE - FORMULA A (ACD·A) - ANTICOAGULANT SOLUTION USER INFORMATION AND LNSTRUCTIONS FOR USE LEAFLET Please read carefully all the following instructions to use the solutions in total security. I. INFORMATION ABOUT THE PRODUCT 1. PRODUCT NAME ACD-A (Acid Citrate Dextrose Solution - Formula A) Anticoagulant Solution. 2. PRODUCT FORMULA Each 1 litre of solution contains: Sodium Citrate Ph. Eur. 22.0 g (2.2% weight in volume) Citric Acid, monohydrate Ph. Eur. 8.0 g (0.8% weight in volume as monohydrate) Glucose, monohydrate Ph. Eur. 24.5 g (2.45% weight in volume as monohydrate) Water for Injections Ph. Eur. to 1000 ml 3. PHARMACEUTICAL FORM OF THE PRODUCT ACD-A Anticoagulant Solution is a sterile, pyrogen-free, clear, colourless anticoagulant solution in printed PVC bags, each with a laminated polypropylene overwrap. Product is presented in 500 ml, or 750 ml volumes. 4. PHARMACO-THERAPEUTIC GROUP Whole Blood Anticoagulant Solution. I I. THERAPEUTIC INDICATIONS ACD-A Anticoagulant Solution is for use only for the anticoagulation of whole blood as part of automated apheresis procedures. III. IMPORTANT INFORMATION 1. CONTRAINDICATIONS None known. 2. PRECAUTIONS FOR USE - Do not administer directly as an intravenous solution. - Do not use unless solution is clear. - Do not use if unit is damaged. - Discard any unused product. - Do not re-use the solution bag. 3. INTERACTIONS WITH MEDICAMENTS AND OTHER FORMS OF INTERACTION Medicaments should not be added to ACD-A Anticoagulant Solution. 4. SPECIAL WARNINGS - CAUTION: This device contains di(2-ethylhexyl) phthalate (DEHP). Precautions should be taken to limit long-term exposure to DEHP in certain groups of patients who, based on animal data, may be at r קרא את המסמך השלם